Current Situation and Challenges in Vitreous Substitutes
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Vitreo-retinal disorders constitute a significant portion of treatable ocular diseases. These pathologies often require vitreo-retinal surgery and, as a consequence, the use of vitreous substitutes. Nowadays, the vitreous substitutes that are used in clinical practice are mainly divided into gases (air, SF6, C2F6, C3F8) and liquids (perfluorocarbon liquids, silicone oils, and heavy silicone oils). There are specific advantages and drawbacks to each of these, which determine their clinical indications. However, developing the ideal biomaterial for vitreous substitution continues to be one of the most important challenges in ophthalmology, and a multidisciplinary approach is required. In this sense, recent research has focused on the development of biocompatible, biodegradable, and injectable hydrogels (natural, synthetic, and smart), which also act as medium and long-term internal tamponade agents. This comprehensive review aims to cover the main characteristics and indications for use of the extensive range of vitreous substitutes that are currently used in clinical practice, before going on to describe the hydrogels that have been developed recently and which have emerged as promising biomaterials for vitreous substitution
Description
Bibliographic citation
Mondelo-García, C., Bandín-Vilar, E., García-Quintanilla, L., Castro-Balado, A., del Amo, E.M., Gil-Martínez, M., Blanco-Teijeiro, M.J., González-Barcia, M., Zarra-Ferro, I., Fernández-Ferreiro, A. and Otero-Espinar, F.J. (2021), Current Situation and Challenges in Vitreous Substitutes. Macromol. Biosci. 2100066. https://doi.org/10.1002/mabi.202100066
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1002/mabi.202100066Sponsors
C.M.-G., E.B.-V., L.G.-Q., and A.F.-F. are grateful to the Carlos III Health Institute for financing the CM18/00090, CM20/00135, CM20/00024, and JR18/00014 personnel contracts. This work was partially supported by the following projects of Carlos III Health Institute (PI17/00940 and PI20/00719)
Rights
© 2021 The Authors. Macromolecular Bioscience published by Wiley‐VCH GmbH This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes
Atribución-NoComercial 4.0 Internacional
Atribución-NoComercial 4.0 Internacional



